Europe Sports Medicine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

Europe Sports Medicine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

Over the next five years, the European sports medicine market is expected to grow at a CAGR of 5.2%.

During the COVID-19 pandemic, the sports medicine market encountered a setback due to the deferral and cancellation of a range of sports events, which led to a decline in sports injuries. For instance, in March 2020, the International Olympic Committee postponed the 2020 Tokyo Olympics and Paralympics to 2021. Such incidents adversely impacted market growth. During this time, medical professionals and specialists were instructed to only perform emergency and critical surgical procedures. However, in 2021, the sports medicine industry has shown a sturdy recovery, owing to a surge in demand for sports medicine products and the increasing relaxation of restrictions, which has led to a rise in the number of sports activities globally. This is expected to grow further in the upcoming years. Moreover, the market growth is stabilizing in the current scenario after COVID-19 as worldwide restrictions have eased and various services have been resumed.

The factors driving the growth of the market are the rising incidence of sports injuries, consistent innovation in new products and treatment modalities, and rising demand for minimally invasive surgeries. The incidence of sports injuries has increased over the last few years, primarily due to the growing participation in sports as well as active participation in fitness activities. For instance, an article published in June 2021 by Frontiers in Sports and Active Living reported that the 1-year prevalence of a severe sports injury episode was 31%. The most common injury locations for these injuries were the knee (25%), ankle (20%), and hip/groin (15%). Also, the point prevalence of an ongoing injury episode was 19%. The most common locations were the knee (24%), ankle (24%), and foot (24%). As a result of the high rates of sports-related injuries, there is an increased demand for sports medicine, which is driving the growth of the market under consideration.

Increasing technological advancements and multiple new product innovations in sports medicine will propel the European market's growth. For instance, in May 2021, Smith & Nephew launched a series of pump laparoscopes and arthroscopes to manage fluid and 4K imaging technology for sports medicine surgeons. Similarly, in May 2022, Osstem Europe launched a next-generation implant system, the Key Solution (KS) implant, in Europe. The system, which has a unique internal design, enhances the strength of dental implants and provides a convenient platform for surgery or prosthesis loading. Thus, such developments in implants and their rising demand are propelling the European sports medicine market.

Moreover, the rising use of wearable devices such as fitness bands and other sensors aids in monitoring stress loads and avoiding fatigue-induced injuries in athletes, which has supported the growth of the market for sports medicine. Thus, due to the aforesaid reasons, the market is expected to witness significant growth over the forecast period. However, the high cost of implants and devices may slow down the growth of the market over the forecast period.

An implant is a medical device manufactured to replace a missing biological structure, support a damaged biological structure, or enhance an existing biological structure. Medical implants are man-made devices, in contrast to a transplant, which is transplanted biomedical tissue. Many implants are available, such as prosthetics intended to replace missing body parts, while other implants deliver medication, monitor body functions, or provide support to organs and tissues.

In major sports injuries, meniscus tears are very common, and often total knee replacement is considered for the treatment. However, in regards to the same, active implants have made significant advancements with their surface meniscus implant for the treatment of persistent knee pain. In the event of a serious joint or tissue injury during sports, medical implants are the best choices to treat the injuries, thus this segment is expected to witness significant growth over the forecast period.

The companies are developing absorbable polymer technology, such as calcium polymer composite materials for making these implants.For instance, in September 2022, Image Navigation Ltd. launched its second generation Image Guided Implantology (IGI) system during the European Association for Osseointegration (EAO) Congress in Geneva. Similarly, in May 2022, European Research and Innovation magazine reported on the new technology of using spun silk in the next generation of eye and knee implants. The silk protein implant acts as a scaffold for bone and connective tissue growth, allowing slow-repairing cartilage to regenerate.Currently, the study is under clinical trial. Such technological advancements will offer unprecedented growth opportunities for segment expansion over the forecast period.

Because of all of these factors, the segment is expected to grow significantly over the next few years.

The presence of major market players, favorable reimbursement scenarios, a rising number of medical centers, and growing investment in the development of sports medicine will result in rapid product adoption throughout the country. Furthermore, developed healthcare infrastructure, as well as increasing adoption of technologically advanced devices to treat sports injuries, are key factors driving the size of the German sports medicine market.

Key players dealing in the German market have built a vast product portfolio and established their presence in all major European countries. For instance, in June 2022, NG Medical GmbH, a medical device manufacturer exclusively focused on creating innovative technologies for spinal applications, launched its new product, the ART Fixation System, in Europe.

Furthermore, research and clinical studies are also fueling the growth of the market in the country. For instance, an article published in May 2021 by Knee Surgery, Sports Traumatology, and Arthroscopy Journal described a study conducted in Germany that reported that the arthroscopic popliteal bypass graft technique provided good-to-excellent clinical results in the mid-term follow-up of patients with posterolateral rotational instability (PLRI) and a concomitant posterior cruciate ligament (PCL) injury of the knee. Thus, due to the aforesaid reasons, the region is expected to show significant growth over the forecast period.

The Europe Sports Medicine Market is moderately consolidated due to the presence of fewer companies at the global and regional levels. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known as Arthrex Inc., CONMED Corporation, Johnson & Johnson, Medtronic PLC, Mueller Sports Medicine Inc., Performance Health, Smith & Nephew, Stryker Corporation, Wright Medical Group, Zimmer Biomet Holdings Inc., Ossur, Cramer Products, Karl Storz Gmbh & Co.Kg and Medshape.

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support